Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin Jonaitis

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Brain, Behavior, and Immunity|January 28, 2026
Higher CSF sTREM2 is related to slower hippocampal atrophy and cognitive decline independently of pTau181 levelsHenry Gilreath Stephenson, Tobey J Betthauser, Erin Jonaitis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 16, 2023
Neuropathology-based APOE genetic risk score better quantifies Alzheimer's riskYuetiva Deming, Eva Vasiljevic, Autumn Morrow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 12, 2019
Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease CenterCarey E Gleason, Derek Norton, Megan Zuelsdorff, et al.
Journal of the International Neuropsychological Society : JINS|March 14, 2014
Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's diseaseOzioma C Okonkwo, Jennifer M Oh, Rebecca Koscik, et al.
JAMA Neurology|January 22, 2024
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
JAMA Neurology|March 3, 2025
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-AnalysisGillian T Coughlan, Hannah M Klinger, Rory Boyle, et al.
Nature Aging|November 12, 2024
Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probabilityJoseph Therriault, Shorena Janelidze, Andréa Lessa Benedet, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Brain, Behavior, and Immunity|January 28, 2026
Higher CSF sTREM2 is related to slower hippocampal atrophy and cognitive decline independently of pTau181 levelsHenry Gilreath Stephenson, Tobey J Betthauser, Erin Jonaitis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 16, 2023
Neuropathology-based APOE genetic risk score better quantifies Alzheimer's riskYuetiva Deming, Eva Vasiljevic, Autumn Morrow, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 12, 2019
Association between enrollment factors and incident cognitive impairment in Blacks and Whites: Data from the Alzheimer's Disease CenterCarey E Gleason, Derek Norton, Megan Zuelsdorff, et al.
Journal of the International Neuropsychological Society : JINS|March 14, 2014
Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's diseaseOzioma C Okonkwo, Jennifer M Oh, Rebecca Koscik, et al.
JAMA Neurology|January 22, 2024
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyNicholas J Ashton, Wagner S Brum, Guglielmo Di Molfetta, et al.
JAMA Neurology|March 3, 2025
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-AnalysisGillian T Coughlan, Hannah M Klinger, Rory Boyle, et al.
Nature Aging|November 12, 2024
Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probabilityJoseph Therriault, Shorena Janelidze, Andréa Lessa Benedet, et al.
Pageof 4